VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2015 | Future directions for the treatment of diffuse large B-cell lymphoma

At the 20th Congress of the European Hematology Association (EHA), Christian Gisselbrecht, MD, of Paris Diderot University, Paris, France, highlights the unmet clinical needs and emerging therapeutic options for patients with diffuse large B-cell lymphoma (DLBCL). Research is moving towards targeted agents that utilize the improved understanding of disease biology in patient subgroups with the poorest prognoses.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter